Angelalign Technology

Angelalign Technology EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Angelalign Technology (6699.HK) as of Oct 16, 2026 is 8.07 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 5.19 M USD — a change of 55.56% (higher).

EBITDA

8.07 MUSD

YoY

55.56%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Angelalign Technology is 2024 8.07 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Angelalign Technology was 2023 5.19 M USD. It decreases by 55.56% higher compared to the previous year.

The Angelalign Technology EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
87.86 M USD
Jan 1, 2019
100.70 M USD
Jan 1, 2020
211.34 M USD
Jan 1, 2021
323.33 M USD
Jan 1, 2022
29.63 M USD
Jan 1, 2023
5.19 M USD
Jan 1, 2024
8.07 M USD
The Angelalign Technology EBITDA history
YEAREBITDAYoY
8.07 MUSD+55.56%
5.19 MUSD-82.49%
29.63 MUSD-90.84%
323.33 MUSD+52.99%
211.34 MUSD+109.86%
100.70 MUSD+14.62%
87.86 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Angelalign Technology Stock analysis

What does Angelalign Technology do? Angelalign Technology Inc, listed on the Hong Kong Stock Exchange under ticker 6699.HK with ISIN KYG0405D1051, is a health care company headquartered in Shanghai, China. The company employs 2,424 full-time staff and completed its initial public offering on June 16, 2021. Angelalign Technology operates as an investment holding company focused on providing clear aligner treatment solutions. Its primary offering is the Angelalign clear aligner system, which supports dental professionals throughout the entire treatment process. The system includes digitally-assisted case assessment and treatment planning services, enabling professionals to design, review, and modify treatment plans. It also provides customized, removable clear aligners made from transparent plastic, used to treat malocclusion, and a cloud-based platform called iOrtho. The iOrtho platform allows dental professionals to place orders, review, modify, and finalize treatment plans online with the assistance of medical designers, while also managing patient medical records. The company's website is https://www.angelalign.com. Angelalign Technology Inc. does not disclose specific details about its founding year, key personnel, or acquisition history, and no financial figures beyond employee count are provided in the available information. Angelalign Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Angelalign Technology stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Angelalign Technology is 8.07 M USD in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Angelalign Technology changed from 5.19 M USD to 8.07 M USD, representing a 55.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Angelalign Technology since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Angelalign Technology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Angelalign Technology

All Key Metrics — Angelalign Technology